Shirshendu Sinha

882 total citations
24 papers, 575 citations indexed

About

Shirshendu Sinha is a scholar working on Hematology, Molecular Biology and Pharmacology. According to data from OpenAlex, Shirshendu Sinha has authored 24 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Shirshendu Sinha's work include Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Shirshendu Sinha is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Shirshendu Sinha collaborates with scholars based in United States, Italy and Germany. Shirshendu Sinha's co-authors include Bhanu Prakash Kolla, Larissa L. Loukianova, Angela Dispenzieri, Martha Q. Lacy, Shaji Kumar, Francis K. Buadi, Suzanne R. Hayman, Nuria J. Thusius, S. Vincent Rajkumar and David Dingli and has published in prestigious journals such as Blood, Cancer and Journal of Cell Science.

In The Last Decade

Shirshendu Sinha

22 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shirshendu Sinha United States 10 266 213 138 92 64 24 575
Juan Ouyang China 13 124 0.5× 131 0.6× 37 0.3× 41 0.4× 23 0.4× 35 577
Ting‐Chi Yeh Taiwan 14 158 0.6× 152 0.7× 114 0.8× 37 0.4× 46 0.7× 56 584
Manuela Balocco Italy 13 262 1.0× 139 0.7× 47 0.3× 51 0.6× 46 0.7× 24 580
Uttam Kumar Nath India 12 96 0.4× 87 0.4× 75 0.5× 208 2.3× 60 0.9× 65 575
Berit Jordan Germany 13 60 0.2× 84 0.4× 268 1.9× 195 2.1× 35 0.5× 34 620
M. Joseph John India 11 135 0.5× 100 0.5× 48 0.3× 28 0.3× 29 0.5× 61 522
Roberta Noseda Switzerland 12 49 0.2× 101 0.5× 154 1.1× 79 0.9× 31 0.5× 26 516
Qin Xie China 16 35 0.1× 223 1.0× 169 1.2× 68 0.7× 34 0.5× 42 763
Philip Murphy Ireland 13 203 0.8× 73 0.3× 74 0.5× 23 0.3× 42 0.7× 54 533
Renee Perdok United States 13 742 2.8× 80 0.4× 25 0.2× 37 0.4× 77 1.2× 20 1.8k

Countries citing papers authored by Shirshendu Sinha

Since Specialization
Citations

This map shows the geographic impact of Shirshendu Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirshendu Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirshendu Sinha more than expected).

Fields of papers citing papers by Shirshendu Sinha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirshendu Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirshendu Sinha. The network helps show where Shirshendu Sinha may publish in the future.

Co-authorship network of co-authors of Shirshendu Sinha

This figure shows the co-authorship network connecting the top 25 collaborators of Shirshendu Sinha. A scholar is included among the top collaborators of Shirshendu Sinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirshendu Sinha. Shirshendu Sinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sinha, Shirshendu, et al.. (2023). Substance Use Disorders and Sleep. Psychiatric Annals. 53(11). 508–513.
2.
3.
Sinha, Shirshendu, et al.. (2022). Psychosocial considerations in the combined bariatric surgery and organ transplantation population: a review of the overlapping pathologies and outcomes. Current Opinion in Organ Transplantation. 27(6). 514–522. 10 indexed citations
4.
Sinha, Shirshendu, et al.. (2021). Challenges in the Treatment of Restless Legs Syndrome: A Case Report. Journal of Primary Care & Community Health. 12. 3667705158–3667705158. 3 indexed citations
5.
Kolla, Bhanu Prakash, et al.. (2020). Evidence-Based Pharmacotherapies for Alcohol Use Disorder. Mayo Clinic Proceedings. 95(9). 1964–1977. 52 indexed citations
6.
Sinha, Shirshendu, et al.. (2020). 110 Implementation of Personalized Medicine in a Community Psychiatry Practice. CNS Spectrums. 25(2). 271–271. 1 indexed citations
7.
Sinha, Shirshendu, et al.. (2019). Wernicke Encephalopathy—Clinical Pearls. Mayo Clinic Proceedings. 94(6). 1065–1072. 84 indexed citations
8.
Roy, Bhaskar, Guido Schwarzer, Michael G. Silverman, et al.. (2018). Comparison of treatment options for depression in heart failure: A network meta-analysis. Journal of Psychiatric Research. 108. 7–23. 35 indexed citations
9.
Maiti, Abhishek, et al.. (2016). Antidepressant Prescription in the Geriatric Population. JAMA Internal Medicine. 176(11). 1608–1608. 2 indexed citations
10.
Sinha, Shirshendu & Ajay M. Shah. (2016). Pharmacotherapy of Tobacco Use Disorder. 11(9). 8–12. 2 indexed citations
11.
Sinha, Shirshendu, et al.. (2015). Sleep Disturbances and Behavioral Disturbances in Children and Adolescents. Psychiatric Clinics of North America. 38(4). 705–721. 9 indexed citations
12.
Modesto‐Lowe, Vania, et al.. (2015). Universal precautions to reduce stimulant misuse in treating adult ADHD. Cleveland Clinic Journal of Medicine. 82(8). 506–512. 3 indexed citations
13.
Micallef, Ivana N., Shirshendu Sinha, Dennis A. Gastineau, et al.. (2012). Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization. Biology of Blood and Marrow Transplantation. 19(1). 87–93. 71 indexed citations
14.
Kumar, Shaji, Martha Q. Lacy, Angela Dispenzieri, et al.. (2011). Early versus delayed autologous transplantation after immunomodulatory agents‐based induction therapy in patients with newly diagnosed multiple myeloma. Cancer. 118(6). 1585–1592. 82 indexed citations
15.
Kapoor, Prashant, Rafaël Fonseca, S. Vincent Rajkumar, et al.. (2010). Evidence for Cytogenetic and Fluorescence In Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies. Mayo Clinic Proceedings. 85(6). 532–537. 40 indexed citations
16.
Sinha, Shirshendu, D A Gastineau, Ivana N. Micallef, et al.. (2010). Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention. Bone Marrow Transplantation. 46(7). 943–949. 54 indexed citations
17.
Kumar, Shaji, Angela Dispenzieri, Martha Q. Lacy, et al.. (2010). Changes in serum‐free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis. American Journal of Hematology. 86(3). 251–255. 57 indexed citations
18.
Sinha, Shirshendu, S. Vincent Rajkumar, Martha Q. Lacy, et al.. (2009). Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma. British Journal of Haematology. 148(6). 853–858. 8 indexed citations
19.
Sinha, Shirshendu, Dennis A. Gastineau, William J. Hogan, et al.. (2009). Predicting Poor Peripheral Blood Stem Cell Mobilization in Multiple Myeloma (MM) Using Initial Peripheral CD34 Counts: Developing Target-Based Cut-Points for Early Intervention.. Blood. 114(22). 3231–3231. 1 indexed citations
20.
Kapoor, Prashant, Rafaël Fonseca, S. Vincent Rajkumar, et al.. (2009). Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.. Blood. 114(22). 1802–1802. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Ouyang Breakdown of academic impact, for papers by Ting‐Chi Yeh Breakdown of academic impact, for papers by Manuela Balocco Breakdown of academic impact, for papers by Uttam Kumar Nath Breakdown of academic impact, for papers by Berit Jordan Breakdown of academic impact, for papers by M. Joseph John Breakdown of academic impact, for papers by Roberta Noseda Breakdown of academic impact, for papers by Qin Xie Breakdown of academic impact, for papers by Philip Murphy Breakdown of academic impact, for papers by Renee Perdok
Rankless by CCL
2026